Clinical Trial

Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"

Study acronym: MyaRESP
Recruiting
View on ClinicalTrials.gov →
Summary
Individuals with MG (IwMG) experience shortness of breath that may be activity-related, occur at rest and even happen during sleep. Dyspnea is a complex, multidimensional and multifactorial symptom involving sensory perception, cognition and emotion. Identifying the cause(s) of dyspnea in MG may assist in finding therapeutic strategies, reducing discomfort, improving QoL and potentially limiting respiratory deterioration and incidence of MG crisis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-04; most recent amendment 2026-05-04.
Status change: Not Yet Recruiting → Recruiting 2026-05-04
Trial Details
NCT Number NCT06866652
Lead Sponsor Institut de Myologie, France
Collaborators: APHP
Conditions Myasthenia Gravis, Dyspnea
Enrollment 50 participants
Start Date 2026-04-08
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-08